Rick Wise
Stock Analyst at Stifel
(4.54)
# 287
Out of 4,761 analysts
229
Total ratings
67.03%
Success rate
14.16%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $39.16 | +22.57% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $105.36 | +13.90% | 17 | Feb 10, 2025 | |
| CNMD CONMED | Maintains: Buy | $72 → $75 | $61.31 | +22.33% | 10 | Feb 6, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $75 → $90 | $74.71 | +20.47% | 23 | Jan 30, 2025 | |
| SYK Stryker | Maintains: Buy | $400 → $440 | $386.41 | +13.87% | 16 | Jan 29, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $130 → $138 | $103.63 | +33.17% | 14 | Jan 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Hold | $170 → $155 | $159.68 | -2.93% | 6 | Jan 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $130 → $135 | $133.17 | +1.37% | 19 | Jan 23, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $525 → $610 | $606.57 | +0.57% | 17 | Dec 5, 2024 | |
| MASI Masimo | Reiterates: Buy | $170 → $190 | $177.21 | +7.22% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $33.44 | +13.64% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $9.66 | -17.18% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $8.78 | +82.23% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $74.50 | +10.07% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $92.09 | +10.76% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $28.82 | +4.09% | 5 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $87.94 | -1.07% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $280 | $227.93 | +22.84% | 7 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $72 | $47.99 | +50.03% | 5 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $7.44 | +61.29% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $100.92 | -25.68% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $34 | $24.36 | +39.57% | 5 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $32.12 | -25.28% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $6 | $0.96 | +525.00% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $15.48 | +61.50% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $52.61 | +112.89% | 5 | Oct 2, 2020 |
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $39.16
Upside: +22.57%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $105.36
Upside: +13.90%
CONMED
Feb 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $61.31
Upside: +22.33%
Edwards Lifesciences
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $74.71
Upside: +20.47%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $386.41
Upside: +13.87%
Zimmer Biomet Holdings
Jan 23, 2025
Maintains: Buy
Price Target: $130 → $138
Current: $103.63
Upside: +33.17%
Johnson & Johnson
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $159.68
Upside: -2.93%
Abbott Laboratories
Jan 23, 2025
Maintains: Buy
Price Target: $130 → $135
Current: $133.17
Upside: +1.37%
Intuitive Surgical
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $606.57
Upside: +0.57%
Masimo
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $177.21
Upside: +7.22%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $33.44
Upside: +13.64%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $9.66
Upside: -17.18%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $8.78
Upside: +82.23%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $74.50
Upside: +10.07%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $92.09
Upside: +10.76%
Sep 13, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $28.82
Upside: +4.09%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $87.94
Upside: -1.07%
Jul 26, 2024
Maintains: Buy
Price Target: $270 → $280
Current: $227.93
Upside: +22.84%
Jul 25, 2024
Maintains: Buy
Price Target: $70 → $72
Current: $47.99
Upside: +50.03%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $7.44
Upside: +61.29%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $100.92
Upside: -25.68%
Mar 7, 2024
Maintains: Buy
Price Target: $32 → $34
Current: $24.36
Upside: +39.57%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $32.12
Upside: -25.28%
Oct 13, 2023
Maintains: Buy
Price Target: $26 → $6
Current: $0.96
Upside: +525.00%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $15.48
Upside: +61.50%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $52.61
Upside: +112.89%